483
Catalent Maryland IncCatalent Maryland Inc – FDA 483, Apr 28, 2025
Record Details
Catalent Maryland, Inc., a gene therapy manufacturer in Harmans, MD, was cited for multiple deficiencies during an FDA inspection. Observations included a lack of identity testing for incoming drug substance, inadequate sterility testing procedures, and unqualified manufacturing equipment. Further issues involved a deficient environmental monitoring program, inadequate personnel qualification for vial inspection, and failure to follow record retention procedures.
View Company Profile
ID · a1f090bf-4d0e-40aa-af63-d03a29bdf9a7
Other documents for Catalent Maryland Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.